Forecast & Rating4 analysts currently cover Nuvectis Pharma, of which 4 give a positive rating. The average price target is $31.00, about 60.5% upside from the current price of $19.31. Coverage is limited, so the data is for reference only. Data as of Jul 23, 2026; this does not constitute investment advice.
Jul 23, 2026
Price forecast
$31.0060.54%
Forecast & RatingStrong buy
4analysts
Strong buy75.00%
Buy25.00%
Hold0.00%
Sell0.00%
Strong sell0.00%
Strong buy
3
Buy
1
Hold
0
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 19, 2026
Forecast met34.5%
Stock price$19.31
Average forecast price$18.2
Highest forecast price$25
Lowest forecast price$10
Average forecast price
$18.2
Highest forecast price
$25
Lowest forecast price
$10
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.